Company profile - Bet site
To generate a new password, please provide the email address with which you have registered to our portal before.

After clicking the “Send” button, we will send the information about generating a new password to the specified email address.
E-mail:
Please check your inbox! We have sent the information necessary for generating a new password to the specified email address.
An error has occured. There is no user in the system with the specified e-mail address.
Please provide the email address with which you have registered to our portal before.
E-mail:
Two-factor reset email successfully sent.
Failed to send the reset email.
false
Richter Gedeon Nyrt.
Gedeon Richter Plc.
Richter Gedeon share

Gedeon Richter Plc.

  • Introduction
  • Trading data
  • Financials
  • Shareholders, management
  • Publications
  • Product features
Full Name Chemical Works of Gedeon Richter Plc.
Short name Gedeon Richter Plc.
Sector Pharmaceuticals
Contact
HU-1103 Budapest, Gyömrői út 19-21.
Phone: +36-1-431-4027
Fax: -
Investor Relations
Katalin Ördög
Phone: +36-1-431-5680
Fax: +36-1-261-2158
Auditor Deloitte Co. Ltd.
Business activity Founded in 1901 by Gedeon Richter, the plant was transformed into a business entity in 1923. Since 1997, it has been the largest domestic drug manufacturer. Its main activity is the manufacturing and distribution of active ingredients and generic pharmaceuticals. Richter has now grown into a multinational company of the Central and Eastern European region. Due to a market network unique in the region and covering five continents, the company s products are available in nearly one hundred countries worldwide. Also unique among Hungarian companies is its network of market interests, comprising the member states of the European Union, the United States of America, the CIS states, Japan and the Eastern region. It operates an extensive marketing and distribution network in Hungary, the CIS states and Eastern Europe.
Listed securities of the issuer
Name Ticker ISIN
RICHTER 2031 HUF Bond RICHTER31 HU0000360441
Richter Gedeon share RICHTER HU0000123096
Basic Information
Ticker RICHTER
ISINHU0000123096
Date of listing09 Nov 1994
Currency of tradingHUF
Face Value100 HUF
Number of securities listed186,374,860
Market Capitalisation (HUF million)1,609,347
> Split (S)/Reverse split (R)
11 Jul 2013 S (1 : 10)
P/BV
P/BV* 1.8468
* Calculating based on the capitalisation of the actual series only
Performance
* annualized yield

Key annual data

Audited, consolidated, in compliance with IFRS (Business Year: January 1 - December 31)
20191 20201
(million HUF) (million HUF)
Total revenues 507,794 566,776
Operating Profit (EBIT) 39,896 115,089
Net income from financial activities 10,294 -825
Profit before tax 50,848 115,164
Profit after tax 48,430 106,052
Dividend per (ordinary) share 63.06 HUF 225 HUF
Fixed Assets 449,071 499,071
Total liabilities 133,778 134,650
Share capital 18,638 18,638
Shareholders equity 724,873 813,939
Total assets 858,651 948,589
Number of employees (at business year end) 13,025 12,842
(1) Audited, consolidated, in compliance with IFRS (Business Year: January 1 - December 31)

Selected financial ratios

Ratios are based on data submitted by the company
2019 2020
Equity Ratio 0.18 0.17
Return on assets (ROA) 0.07 0.13
Return on equity (ROE) 0.06 0.11

Mid-year reports

Non-audited, consolidated, in compliance with IFRS (Business Year: January 1 - December 31)
Key P&L Figures Jan 2020 - Sep 20201 Jan 2021 - Sep 20211
(million HUF) (million HUF)
Net sales 416,389 454,321
Operating profit (EBIT) 82,283 93,934
Net income from financial activities 4,921 1,806
Profit before tax 89,036 98,159
Profit after tax 84,304 94,121
Key Balance Sheet Items 30 Sep 2020 30 Sep 2021
(million HUF) (million HUF)
Fixed Assets 476,783 695,407
Intangible Assets 140,882 256,482
Tangible assets 245,024 263,236
Invested financial assets 31,626 164,868
Current Assets 452,534 418,352
Inventory 112,978 127,765
Total assets 929,317 1,113,759
Shareholders equity 796,429 871,406
Share capital 18,638 18,638
Long-term liabilities 23,479 94,178
Short-term liabilities 109,409 148,175
Total liabilities and shareholders equity 929,317 1,113,759
(1) Non-audited, consolidated, in compliance with IFRS (Business Year: January 1 - December 31)
Shareholders exceeding 5% stake with respect to the listed series
Name Shareholding (%) Share piece
Maecenas Universitatis Corvini Alapítvány 10.00 18,637,486
Mathias Corvinus Collegium Alapítvány 10.00 18,637,486
Nemzeti Egészségügyi és Orvosképzésért Alapítvány 5.25 9,777,658
FMR LLC 5.07 9,457,941
Note: When determining the Free Float for a particular series, all the securities of the company shall be regarded to be publicly held other than (i) the stock of securities held by holders with direct holdings of at least 5% of the total number of securities, (ii) securities in the possession of custodians, provided the certificate available to the custodian verifies that the particular person holds at least 5% of the total number of securities outstanding. The value of the free float is based on the data provided by the issuer.
Management
Management Board BOGSCH Erik (chairman), ORBÁN Gábor, Dr. GULÁCSI Gábor, LANTOS Csaba, Dr. HARDY Ilona, Dr. BAGDY György, Prof. Dr. VIZI E. Szilveszter, PANDURICS Anett, SZÉCSÉNYI Bálint, Dr. CSERHÁTI Péter
Management ORBÁN Gábor (CEO), Dr. GULÁCSI Gábor (CFO), Dr. GREINER István (research director), Dr. THALER György (development director), HORVÁTH Tibor (commercial director)
Supervisory Board Dr. CHIKÁN Attila (chairman), Dr. BEDROS Jonathán Róbert, Dr. HARMATH Zsolt, KOVÁCSNÉ CSIKÓS Klára, KOVÁCSNÉ dr. KOZSDA Éva
Publication News
01 Dec 2021 14:37 Composition of share capital of the Company and number of voting rights attached to the shares on 30 November, 2021
08 Nov 2021 00:01 Richter - Interim report to the Budapest Stock Exchange 9 months to September 2021
02 Nov 2021 09:58 Composition of share capital of the Company and number of voting rights attached to the shares on 31 October, 2021.
29 Oct 2021 13:55 Cariprazine (VRAYLAR®) Met Primary Endpoint in Phase 3 Study as an Adjunctive Treatment for Major Depressive Disorder
25 Oct 2021 14:55 Extraordinary Information
30 Sep 2021 13:25 Composition of share capital of the Company and number of voting rights attached to the shares on 30 September, 2021.
20 Sep 2021 13:35 Extraordinary Information
31 Aug 2021 14:36 Composition of share capital of the Company and number of voting rights attached to the shares on 31 August, 2021.
13 Aug 2021 14:34 Resolution no. 75/XBOND/2021 of the Budapest Stock Exchange Ltd. registering into exchange trading the bonds issued by Chemical Works of Gedeon Richter Plc., as of August 17, 2021. The First Day of Trading: August 17, 2021.
11 Aug 2021 09:20 Extraordinary Information
Publication Report
16 Apr 2021 14:00 Annual reports 2020
03 Aug 2021 00:01 Gedeon Richter Plc. - 2021 Half-yearly Report
16 Apr 2021 14:10 CG Declaration
Publication Articles of Association
18 Jul 2014 12:08 Articles of Associations
Publication Voting rights, registered capital
01 Dec 2021 14:37 Composition of share capital of the Company and number of voting rights attached to the shares on 30 November, 2021
Publication Corporate Action Timetable
27 Apr 2021 14:51 Amended corporate action timetable for year 2021
/pfile/file?path=/site/Angol/Documents/ker_ido_EN_02032015.pdf
/pfile/file?path=/site/Angol/Documents/link_6_fejezetEN.pdf
/pfile/file?path=/site/Angol/Documents/BSE_Release_certificates.pdf
/pfile/file?path=/site/Magyar/Dokumentumok/Kereskedesi_adatok/Links/xtend_ausz_hatalyos_2018_12_04_10fejezet
Name of securityRichter Gedeon share
IssuerChemical Works of Gedeon Richter Plc.
Equity classOrdinary share
Type of securityRegistered
Form of securityDematerialised
Code of security (ISIN)HU0000123096
Ticker symbolRICHTER
Face value100 HUF
Number of securities listed186,374,860
Rights to dividendsFull year
Listing date09 Nov 1994
First Trading Day09 Nov 1994
MarketPrime
Trading Unit
Currency of tradingHUF
Trading time
Listing price1,330